Artiva Biotherapeutics, Inc. (35) | Business Operations (7)

Browse by Subcategory

Recent Contracts

Amendment No. 1 to Strategic Collaboration Agreement, dated October 18, 2021, by and between the Registrant and Affimed GmbH (Filed With SEC on December 16, 2021)
Form of Indemnification Agreement by and between the Registrant and its directors and officers (Filed With SEC on April 8, 2021)
Master Agreement for Manufacturing Services, dated March 16, 2020, by and between the Registrant and Green Cross Cell Corporation (Filed With SEC on April 8, 2021)
Amendment No. 1 to Master Agreement for Manufacturing Services, dated June 16, 2020, by and between the Registrant and Green Cross Cell Corporation (Filed With SEC on April 8, 2021)
Master Research Services Agreement, dated August 3, 2020, by and between the Registrant and Green Cross LabCell Corporation (Filed With SEC on April 8, 2021)
Exclusive License and Collaboration Agreement, dated January 27, 2021, by and between the Registrant and Merck Sharp & Dohme Corp (Filed With SEC on April 8, 2021)
Strategic Collaboration Agreement, dated November 5, 2020, by and between the Company and Affimed GmbH (Filed With SEC on April 8, 2021)